Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06049849 · ClinicalTrials.gov registry record · NA
Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators
A NA study of Chronic Stroke, sponsored by First Institute of All Medicines.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT06049849: Completed NA study of Chronic Stroke, sponsored by First Institute of All Medicines.
NCT06049849 is a NA study of Chronic Stroke that has completed, run by First Institute of All Medicines. The registered enrollment target is 46 participants, above the 41-participant average among 20 other Chronic Stroke trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06049849, a NA study of Chronic Stroke, has completed, sponsored by First Institute of All Medicines.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
Study objective The purpose of this clinical research is to verify if the patient with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. Study design This study is a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. At least 46 patients with chronic stroke will participate in the live-in observational study in a Tesla MedBed Center. Study patient population The adult patient with a chronic stroke which was defined as a stroke occurred at least 6 months ago with a significant disability unable to have an independent life, is to be considered as a qualified participant.
Primary Outcome
If the damaged brain is repaired, the participant can perform daily activities.
Conditions Studied
Interventions
- DEVICE Biophoton Energizing Brain and Whole Body
Study Locations (1)
Pennsylvania
- Tesla MedBed Center at Butler-PA - Butler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-10-31 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT06049849 record still lists
NCT06049849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, above the 41-participant average among 20 other Chronic Stroke trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Biophoton Energizing Brain and Whole Body is the first listed.
NCT06049849 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06049849 about?
NCT06049849 is a clinical study titled "Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators". Study objective The purpose of this clinical research is to verify if the patient with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. Study design This study is a...
What is the current status of trial NCT06049849?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-10-31. Estimated completion is 2024-12-31.
What conditions does trial NCT06049849 study?
This clinical trial studies the following conditions: Chronic Stroke.
What interventions are being tested in trial NCT06049849?
The interventions under investigation include: Biophoton Energizing Brain and Whole Body (DEVICE).
Who is sponsoring clinical trial NCT06049849?
This trial is sponsored by First Institute of All Medicines, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06049849 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06049849's enrollment target sits among peer trials
46 6th of 20 higher than 15 of 20 other Chronic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
Effect of NMES on Balance and Fall Risk in Chronic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Paired Vagus Nerve Stimulation Mechanisms
RECRUITING · NA
-
Home-based FES Training in People With Chronic Stroke
RECRUITING · NA
-
Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI